These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15952917)

  • 21. Adipocytokines: emerging therapeutic targets.
    Matsuzawa Y
    Curr Atheroscler Rep; 2005 Feb; 7(1):58-62. PubMed ID: 15683604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlations between the expression of the insulin sensitizing hormones, adiponectin, visfatin, and omentin, and the appetite regulatory hormone, neuropeptide Y and its receptors in subcutaneous and visceral adipose tissues.
    Nway NC; Sitticharoon C; Chatree S; Maikaew P
    Obes Res Clin Pract; 2016; 10(3):256-63. PubMed ID: 26067914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adipocytokines: factors with various suggested functions].
    Zhu Y; Huang D
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Apr; 27(2):476-80. PubMed ID: 20481343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of the fat tissue and its hormones in the mechanisms of insulin resistance and the development of type 2 diabetes mellitus].
    Klebanova EM; Balabolkin MI; Kreminskaia VM
    Klin Med (Mosk); 2007; 85(7):20-7. PubMed ID: 17882804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pro-inflammatory cytokines and adipose tissue.
    Coppack SW
    Proc Nutr Soc; 2001 Aug; 60(3):349-56. PubMed ID: 11681809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease.
    Schäffler A; Schölmerich J; Büchler C
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):273-80. PubMed ID: 16265231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipocyte-brain: crosstalk.
    Schulz C; Paulus K; Lehnert H
    Results Probl Cell Differ; 2010; 52():189-201. PubMed ID: 20865382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin.
    Derosa G; Salvadeo SA; D'Angelo A; Fogari E; Ragonesi PD; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Cicero AF
    Arch Med Res; 2008 May; 39(4):412-9. PubMed ID: 18375253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity.
    Dyck DJ; Heigenhauser GJ; Bruce CR
    Acta Physiol (Oxf); 2006 Jan; 186(1):5-16. PubMed ID: 16497175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of obesity-related peptides on the vasculature.
    Skilton MR; Celermajer DS
    Curr Vasc Pharmacol; 2006 Jan; 4(1):79-85. PubMed ID: 16472179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.
    Schernthaner GH; Schernthaner G
    Scand J Clin Lab Invest Suppl; 2005; 240():30-40. PubMed ID: 16112958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central role of the adipocyte in the insulin-sensitising and cardiovascular risk modifying actions of the thiazolidinediones.
    Smith SA
    Biochimie; 2003 Dec; 85(12):1219-30. PubMed ID: 14739074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adipocytokines and the metabolic complications of obesity.
    Rasouli N; Kern PA
    J Clin Endocrinol Metab; 2008 Nov; 93(11 Suppl 1):S64-73. PubMed ID: 18987272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity, adipocytokines, and insulin resistance in breast cancer.
    Rose DP; Komninou D; Stephenson GD
    Obes Rev; 2004 Aug; 5(3):153-65. PubMed ID: 15245384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on visfatin/pre-B cell colony-enhancing factor, an ubiquitously expressed, illusive cytokine that is regulated in obesity.
    Stephens JM; Vidal-Puig AJ
    Curr Opin Lipidol; 2006 Apr; 17(2):128-31. PubMed ID: 16531748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship.
    Nishimura F; Iwamoto Y; Mineshiba J; Shimizu A; Soga Y; Murayama Y
    J Periodontol; 2003 Jan; 74(1):97-102. PubMed ID: 12593603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: a prospective study.
    Díaz-Soto G; de Luis DA; Conde-Vicente R; Izaola-Jauregui O; Ramos C; Romero E
    Diabetes Res Clin Pract; 2014 Apr; 104(1):92-6. PubMed ID: 24530118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Insulin resistance: the adipose tissue in the focus].
    Urich E
    Orv Hetil; 2005 Oct; 146(43):2199-207. PubMed ID: 16323566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adipocytokines and metabolic syndrome--molecular mechanism and clinical implication].
    Matsuda M; Shimomura I
    Nihon Rinsho; 2004 Jun; 62(6):1085-90. PubMed ID: 15206145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adipose expression of adipocytokines in women with polycystic ovary syndrome.
    Svendsen PF; Christiansen M; Hedley PL; Nilas L; Pedersen SB; Madsbad S
    Fertil Steril; 2012 Jul; 98(1):235-41. PubMed ID: 22607892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.